Protective immunity to infection by many intracellular pathogens requires recognition by cytotoxic T lymphocytes (CTLs) of antigens presented on major histocompatibility complex (MHC) class I molecules. To be presented for recognition by pathogen-specific CTLs, these antigens must gain access to the host cell class I processing pathway. In the case of intracellular bacterial pathogens, the majority of bacterial proteins are retained within the bacterial membrane and therefore remain inaccessible to the host cell for antigen processing. We have isolated a CTL clone from a C57BL/6 mouse infected with the intracellular gram-positive bacterium Listeria monocytogenes (LM) and have identified the source of the antigen. Using a genomic expression library, we determined that the clone recognizes an antigenic N-formyl peptide presented by the nonpolymorphic murine MHC class Ib molecule, H2-M3. Several lengths of this peptide were able to sensitize cells for lysis by this CTL clone. The source of this antigenic peptide is a 23–amino acid polypeptide encoded at the start of a polycistronic region. Analysis of mRNA secondary structure of this region suggests that this polypeptide may be a leader peptide encoded by a transcriptional attenuator.
Skip Nav Destination
Article navigation
18 May 1998
Article|
May 18 1998
H2-M3 Restricted Presentation of a Listeria-derived Leader Peptide
Michael F. Princiotta,
Michael F. Princiotta
From the *National Jewish Medical and Research Center and ‡Department of Immunology, University of Colorado Health Sciences Center, Denver, Colorado 80206; and the ‡Howard Hughes Medical Institute and Department of Immunology, University of Washington, Seattle, Washington 98195
Search for other works by this author on:
Uwe D. Staerz
Uwe D. Staerz
From the *National Jewish Medical and Research Center and ‡Department of Immunology, University of Colorado Health Sciences Center, Denver, Colorado 80206; and the ‡Howard Hughes Medical Institute and Department of Immunology, University of Washington, Seattle, Washington 98195
Search for other works by this author on:
Michael F. Princiotta
From the *National Jewish Medical and Research Center and ‡Department of Immunology, University of Colorado Health Sciences Center, Denver, Colorado 80206; and the ‡Howard Hughes Medical Institute and Department of Immunology, University of Washington, Seattle, Washington 98195
Laurel L. Lenz
Michael J. Bevan
Uwe D. Staerz
From the *National Jewish Medical and Research Center and ‡Department of Immunology, University of Colorado Health Sciences Center, Denver, Colorado 80206; and the ‡Howard Hughes Medical Institute and Department of Immunology, University of Washington, Seattle, Washington 98195
Address correspondence to Uwe Staerz, Department of Medicine, National Jewish Medical and Research Center, K405, 1400 Jackson St., Denver, CO 80206. Phone: 303-398-1767; Fax: 303-398-1396; E-mail: [email protected]
Received:
January 29 1998
Revision Received:
March 20 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 187 (10): 1711–1719.
Article history
Received:
January 29 1998
Revision Received:
March 20 1998
Citation
Michael F. Princiotta, Laurel L. Lenz, Michael J. Bevan, Uwe D. Staerz; H2-M3 Restricted Presentation of a Listeria-derived Leader Peptide . J Exp Med 18 May 1998; 187 (10): 1711–1719. doi: https://doi.org/10.1084/jem.187.10.1711
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement